25 earlier Form 4 trades (code P or S) here by this insider (13 buys, 12 sales), the last on Jan 28, 2025.
+5.2% median (+73.4% mean) 90-day return after 12 previous buys.
The trade is 41.8% of the 47,900 shares held after it.
No other insider bought within 30 days.
Insider activity: Major Member of GP Wu Xianghong bought about $13.8K of UCASU on May 2, 2025, the largest insider purchase at the company on our record.
24 earlier Form 4 trades (code P or S) here by this insider (12 buys, 12 sales), the last on Jan 27, 2025.
+14.7% median (+86.3% mean) 90-day return after 11 previous buys.
The trade is 71.7% of the 27,900 shares held after it.
No other insider bought within 30 days.
Insider activity: Major Member of GP Wu Xianghong bought about $13.6K of UCASU on Jan 28, 2025, the largest insider purchase at the company on our record.
21 earlier Form 4 trades (code P or S) here by this insider (9 buys, 12 sales), the last on Nov 4, 2024.
+29.1% median (+108.9% mean) 90-day return after 9 previous buys.
The trade is 78.5% of the 7,850 shares held after it.
No other insider bought within 30 days.
Insider activity: Majority Member of GP Wu Xianghong bought about $3.7K of UCASU on Nov 29, 2024, the largest insider purchase at the company on our record.
21 earlier Form 4 trades (code P or S) here by this insider (9 buys, 12 sales), the last on Nov 4, 2024.
+29.1% median (+108.9% mean) 90-day return after 9 previous buys.
The trade is 10.7% of the 7,850 shares held after it.
No other insider bought within 30 days.
Insider activity: Majority Member of GP Wu Xianghong bought about $503 of UCASU on Nov 29, 2024, the largest insider purchase at the company since 2021.
26 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Revenue growth, YoY-93.9% · 3 pct, universe of 4,657
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
6 not measured: Profitability, Financial health, Insider conviction, Institutional and government, Risk and compliance, US patents
Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
Risk and compliance needs 1 of 4 inputs, 0 present: needs two 10-Ks with a Risk Factors section (not 20-F filers or stubs); no short interest or no free float on file; revenue under $50M or not filed, so a count cannot be scaled to size
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
1 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.